Navidea Biopharmaceuticals (NAVB) Jumps: Stock Rises 5.9% – Tale of the Tape

ZacksNavidea Biopharmaceuticals, Inc (NAVB) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up nearly 45% in the past one-month time frame.

The company has seen no estimate revision over the past 30 days and the Zacks Consensus Estimate has not been in a trend either. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Navidea Biopharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the medical appliances and equipment industry include Natus Medical Inc. (BABY), CryoLife Inc. (CRY) and Cynosure, Inc. (CYNO). All these carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

To read this article on Zacks.com click here.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

Be the first to comment

Leave a Reply